E-cadherin, β-catenin, And α2β1 And α3β1 Integrin Expression In Primary Oral Squamous Cell Carcinoma And Its Regional Metastasis.
Mariana Quirino Silveira Soares, Juliana Andrade Mendonça, Marília Oliveira Morais, Cláudio Rodrigues Leles, Aline Carvalho Batista, Elismauro Francisco de Mendonça
Published 2015 · Medicine, Biology
Download PDFAnalyze on Scholarcy
To investigate E-cadherin, β-catenin, and α2β1 and α3β1 integrins in 40 samples of non-metastatic and metastatic oral squamous cell carcinoma (OSCC) with positive cervical lymph nodes (LN). Immunohistochemistry was used to evaluate expression in the lesion center (LC) and invasive tumor front (ITF) of non-metastatic (n=18) and metastatic (n=22) OSCC and in the LN on the metastatic neoplastic cells (MNC; n=22). In metastatic OSCC, E-cadherin and β-catenin presented significantly lower cytoplasmic membrane expression in the ITF and MNC when compared to the LC and lower cytoplasmic expression in MNC when compared to the LC and ITF (p<0.05). Integrins α2β1 and α3β1 showed high cytoplasmic expression in the LC, ITF and MNC (p>0.05). A positive correlation was observed between E-cadherin cytoplasmic expression and α2β1 (p=0.860) and α3β1 (p=0.975) expression. When comparing the primary sites of metastatic and non-metastatic disease, β-catenin presented lower cytoplasmic membrane (p=0.013) expression in metastatic OSCC. E-cadherin presented low expression and the integrins high expression in both groups. Abnormal expression of β-catenin and E-cadherin associated with high expression of α2β1 and α3β1 integrins contribute to LN metastasis in OSCC.
This paper references
Role of Integrins in the Carcinogenesis of Squamous Cell Carcinoma of the Tongue and Lower Lip
Antônio Luiz Amaral Pereira (2013)
Metastasis from oral cancer: an overview.
Juliana Noguti (2012)
Invasion and Metastasis of Oral Cancer Cells Require Methylation of E-Cadherin and/or Degradation of Membranous β-Catenin
Y. Kudo (2004)
E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior.
M. Foschini (2008)
Elevated Levels of Lewis Y and Integrin α5β1 Correlate with Chemotherapeutic Drug Resistance in Epithelial Ovarian Carcinoma
Zhenhua Hu (2012)
Integrins and metastasis
Kirat Kumar Ganguly (2013)
Is the invasive front of an oral carcinoma the most important area for prognostication?
M. Bryne (1998)
beta-catenin expression pattern in primary oral squamous cell carcinoma.
Zhi-Gang Cai (2008)
Is E-cadherin immunoexpression a prognostic factor for head and neck squamous cell carcinoma (HNSCC)? A systematic review and meta-analysis.
Zhigang Zhao (2012)
Integrin Expression Levels Correlate with Invasion, Metastasis and Prognosis of Oral Squamous Cell Carcinoma
Teruhisa Ohara (2008)
Adhesion molecules in keratinocytes.
Leo Čabrijan (2011)
WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors.
Giuseppe Pannone (2010)
Expression of E-cadherin in primary oral squamous cell carcinoma and metastatic lymph nodes: an immunohistochemical study.
Gurkiran A Kaur (2009)
Expression of p53 and Cyclin D1 in oral squamous cell carcinoma and normal mucosa: An Immunohistochemical study
Uma Swaminathan (2012)
Integrin Regulation of β-Catenin Signaling in Ovarian Carcinoma*
Rebecca J. Burkhalter (2011)
Histological Typing of Cancer and Precancer of the Oral Mucosa
Dr. J. J. Pindborg (1997)
Alpha2beta1 integrin is the major collagen-binding integrin expressed on human Th17 cells.
Marc Boisvert (2010)
Role of integrins in regulating epidermal adhesion, growth and differentiation.
F. Watt (2002)
Association between integrin expression and prognosis in localized prostate cancer.
José Pontes-Júnior (2010)
Detection and analysis of beta-catenin mutations in prostate cancer.
Dennis R Chesire (2000)
The expression of E-cadherin at the invasive tumor front of oral squamous cell carcinoma: immunohistochemical and RT-PCR analysis with clinicopathological correlation.
X. Wang (2009)
Activation of β-catenin signaling is critical for doxorubicin-induced epithelial–mesenchymal transition in BGC-823 gastric cancer cell line
Rongfei Han (2012)
Integrin alpha3beta1-dependent beta-catenin
Y. Kim (2009)
Nuclear expression of E-cadherin in solid pseudopapillary tumors of the pancreas.
S. Serra (2007)
The expression and clinical significance of matrix metalloproteinase 7 and tissue inhibitor of matrix metalloproteinases 2 in clear cell renal cell carcinoma
Hongsheng Lu (2013)
Prognostic and predictive factors in oral cancer: The role of the invasive tumour
A. Bankfalvi (2000)
Evaluation of myosin VI, E-cadherin and beta-catenin immunostaining in renal cell carcinoma
Hanna Ronkainen (2010)
Integrins and cadherins join forces to form adhesive networks
Gregory F Weber (2011)
Mechanistic insights from structural studies of β-catenin and its binding partners
W. Xu (2007)
Nuclear localization of E-cadherin expression in Merkel cell carcinoma.
A. Han (2000)
Zachary Hall (1906)
Correlation of beta-catenin expresssion and metastasis in tongue squamous cell carcinoma
A. Freitas Rde (2010)
Epithelial-mesenchymal transition and tumour invasion.
M. Guarino (2007)
Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas.
Á. Bánkfalvi (2002)
Pathobiology of cancer metastasis: a short account
Liviu Feller (2011)
Elevated expression of integrin αv and β5 subunit in laryngeal squamous-cell carcinoma associated with lymphatic metastasis and angiogenesis.
Feng Li (2013)
Expression of E-Cadherin in Oral Squamous Cell
J. Zhang (2006)
CYR61 and alphaVbeta5 integrin cooperate to promote invasion and metastasis of tumors growing in preirradiated stroma.
Y. Monnier (2008)
Integrin α2β1 Mediates Tyrosine Phosphorylation of Vascular Endothelial Cadherin Induced by Invasive Breast Cancer Cells*
Mehran Haidari (2012)
Convergence of Wnt, beta-catenin, and cadherin pathways.
W. Nelson (2004)
Epithelial-mesenchymal transition in the skin.
Motonobu Nakamura (2011)
Invasion and Metastasis in Colorectal Cancer: Epithelial-Mesenchymal Transition, Mesenchymal-Epithelial Transition, Stem Cells and β-Catenin
T. Brabletz (2005)
Integrin alpha3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and KAI1/CD82.
H. Hashida (2002)
Impaired E-Cadherin Expression and Glutamine Synthetase Overexpression in Solid Pseudopapillary Neoplasm of the Pancreas
V. Audard (2008)
E-cadherin in oral SCC: an analysis of the confusing literature and new insights related to its immunohistochemical expression.
M. Vered (2012)
Suppression of integrin alpha3beta1 in breast cancer cells reduces cyclooxygenase-2 gene expression and inhibits tumorigenesis, invasion, and cross-talk to endothelial cells.
Kara K Mitchell (2010)
α3β1 integrin–CD151, a component of the cadherin–catenin complex, regulates PTPμ expression and cell–cell adhesion
N. Chattopadhyay (2003)
β‐catenin is a target for the ubiquitin–proteasome pathway
H. Aberle (1997)
Cytoplasmic expression of E-cadherin and beta-Catenin correlated with LOH and hypermethylation of the APC gene in oral squamous cell carcinomas.
Shan Gao (2005)
Crosstalk between the alpha2beta1 integrin and c-met/HGF-R regulates innate immunity.
Karissa D. McCall-Culbreath (2008)
A role for cadherins in tissue formation.
L. Larue (1996)
E-cadherin/Catenin Complex Status in Solid Pseudopapillary Tumor of the Pancreas
M. El-Bahrawy (2008)
A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines.
Tetsunari Oyama (1994)
The α₂β₁ integrin is a metastasis suppressor in mouse models and human cancer.
Norma E. Ramirez (2011)
A Role for the Cleaved Cytoplasmic Domain of E-cadherin in the Nucleus*S⃞
E. C. Ferber (2008)
Integrin α9β1 promotes malignant tumor growth and metastasis by potentiating epithelial-mesenchymal transition
Shiv K Gupta (2013)
E-cadherin is a ligand for integrin alpha2beta1.
John D Whittard (2002)
Laminin Interactions with Head and Neck Cancer Cells under Low Fluid Shear Conditions Lead to Integrin Activation and Binding*
Susan M. Fennewald (2012)
Expression of Dickkopf-1 and Beta-Catenin Related to the Prognosis of Breast Cancer Patients with Triple Negative Phenotype
Wen-Huan Xu (2012)
Altered E-cadherin/beta-catenin expression in oral squamous carcinoma with and without nodal metastasis.
Farzana Mahomed (2007)
E-cadherin dysfunction in gastric cancer--cellular consequences, clinical applications and open questions.
Patrícia Carneiro (2012)
Loss of E-Cadherin Expression and Outcome among Patients with Resectable Pancreatic Adenocarcinomas
S. Hong (2011)
α2β1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis
K. Shield (2007)
Loss of Membrane Localization and Aberrant Nuclear E-cadherin Expression Correlates With Invasion in Pancreatic Endocrine Tumors
R. Chetty (2008)
E-cadherin loss promotes the initiation of squamous cell carcinoma invasion through modulation of integrin-mediated adhesion
Weitian Zhang (2006)
Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence.
G. Zulehner (2010)
Prognostic and predictive factors in oral cancer: the role of the invasive tumour front.
Á. Bánkfalvi (2000)
Nuclear localization of E-cadherin but not beta-catenin in human ovarian granulosa cell tumours and normal ovarian follicles and ovarian stroma.
Yoshihiro Ohishi (2011)
CD44 Upregulation in E-Cadherin-Negative Esophageal Cancers Results in Cell Invasion
Grégoire F. Le Bras (2011)
E-cadherin Immunohistochemical Expression as a Prognostic Factor in Infiltrating Ductal Carcinoma of the Breast: a Systematic Review and Meta-Analysis
Bonnie E. Gould Rothberg (2006)
Integrin alpha 3 beta 1 - dependent beta - catenin phosphorylation links epithelial smad signaling to cell contacts
Y. Kim (2009)
Detection and analysis of beta - catenin mutations in
R. ChesireD. (2000)
Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma.
M. Diniz-Freitas (2006)
Decreased E-Cadherin but not β-Catenin Expression is Associated with Vascular Invasion and Decreased Survival in Head and Neck Squamous Carcinomas
K. Kurtz (2006)
This paper is referenced by
Altered β-catenin expression in oral mucosal dysplasia: a comparative study
Brunno Santos de Freitas Silva (2015)
Expression of adhesion proteins (E-cadherin and β-catenin) and cell proliferation (Ki-67) at the invasive tumor front in conventional oral squamous cell and basaloid squamous cell carcinomas.
Carlos Henrique Pereira (2016)
Functional Role of the Chemokine Receptor XCR1 and its Bioengineered Ligand in Oral Squamous Cell Carcinoma (OSCC)
Abdullah Zubir (2018)
miR-134 targets PDCD7 to reduce E-cadherin expression and enhance oral cancer progression.
Shih-Yuan Peng (2018)
Prognostic Prediction of Oral Squamous Cell Carcinoma by E-Cadherin and N-Cadherin Expression in Overall Cells in Tumor Nests or Tumor Cells at the Invasive Front
Yuu Ozaki-Honda (2017)
A three‐dimensional cell culture system as an in vitro canine mammary carcinoma model for the expression of connective tissue modulators
T. Cardoso (2017)
Title Prognostic Prediction of Oral Squamous Cell Carcinoma by E-Cadherin and N-Cadherin Expression in Overall Cells in Tumor Nests or Tumor Cells at the Invasive
Yuu Ozaki-Honda (2019)
Reduced expression of E-cadherin and p120-catenin and elevated expression of PLC-γ1 and PIKE are associated with aggressiveness of oral squamous cell carcinoma.
Y. Jiang (2015)
Activation of adrenergic receptor β2 promotes tumor progression and epithelial mesenchymal transition in tongue squamous cell carcinoma
Haichao Liu (2018)
β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer
Anne-Florence Blandin (2015)
Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis.
Nathália Martins Lopes (2018)
CLIC1 promotes the progression of oral squamous cell carcinoma via integrins/ERK pathways.
J. Feng (2019)